PAVmed Inc (PAVM) has released an update.
PAVmed Inc. has rewarded its stockholders with a sizable distribution of shares in its subsidiary, Lucid Diagnostics, amounting to 6.9% of Lucid’s common stock. This special dividend means each PAVmed shareholder received a proportional share of Lucid stock, with the company retaining a 65.2% stake post-distribution. Additionally, the distribution has led to an adjustment in the exercise price of PAVmed’s Series Z Warrants, effectively lowering it by the value of the dividend distributed.
For further insights into PAVM stock, check out TipRanks’ Stock Analysis page.
